Michael F. Price’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-103,910
Closed -$715K 126
2019
Q3
$715K Sell
103,910
-965
-0.9% -$6.64K 0.1% 89
2019
Q2
$968K Hold
104,875
0.13% 86
2019
Q1
$1.64M Hold
104,875
0.2% 74
2018
Q4
$1.62M Hold
104,875
0.22% 74
2018
Q3
$2.26M Hold
104,875
0.28% 65
2018
Q2
$2.55M Hold
104,875
0.3% 63
2018
Q1
$1.79M Hold
104,875
0.21% 75
2017
Q4
$1.99M Buy
104,875
+50,000
+91% +$947K 0.25% 72
2017
Q3
$966K Sell
54,875
-665,125
-92% -$11.7M 0.13% 80
2017
Q2
$23.9M Hold
720,000
3.1% 8
2017
Q1
$23.1M Buy
720,000
+23,500
+3% +$754K 2.86% 8
2016
Q4
$25.2M Buy
696,500
+227,200
+48% +$8.24M 3.06% 7
2016
Q3
$21.6M Buy
469,300
+29,000
+7% +$1.33M 2.87% 7
2016
Q2
$22.1M Hold
440,300
2.94% 7
2016
Q1
$23.6M Hold
440,300
3.31% 6
2015
Q4
$28.9M Hold
440,300
3.56% 6
2015
Q3
$24.9M Hold
440,300
3.72% 5
2015
Q2
$26M Hold
440,300
3.42% 7
2015
Q1
$27.4M Sell
440,300
-7,200
-2% -$449K 3.63% 7
2014
Q4
$25.7M Sell
447,500
-52,500
-11% -$3.02M 3.14% 9
2014
Q3
$26.9M Hold
500,000
3.35% 7
2014
Q2
$26.2M Buy
500,000
+111,600
+29% +$5.85M 3.21% 6
2014
Q1
$20.5M Sell
388,400
-11,600
-3% -$613K 2.5% 12
2013
Q4
$16M Buy
400,000
+50,000
+14% +$2M 2.07% 22
2013
Q3
$13.2M Hold
350,000
1.76% 22
2013
Q2
$13.7M Buy
+350,000
New +$13.7M 1.84% 21